Answers are grounded in this paper and cite their sources.
The art of oncoimmunovaccinomics will be concisely explained herein. This scientific insight will explore its history cancer immunotherapy, the molecular basis of cancer immunotherapy, cancer immunotherapeutic approach, cancer immunosurveillance and immunoediting, the hallmarks of cancer (can be) revisited, nanotechnology-based cancer immunotherapy, immunovaccinomics, vaccinomics approach, the theory of vaccinology, adversomics, and immunogenomic perspectives.
No takes yet. Share an insight, caveat, or question.
Ikrar et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: